Literature DB >> 31288594

Misidentification of MLL3 and other mutations in cancer due to highly homologous genomic regions.

Timothy G Bowler1, Kith Pradhan1, Yu Kong1, Matthias Bartenstein1, Kerry A Morrone1, Ashwin Sridharan1, Rachel M Kessel1, Aditi Shastri1, Orsi Giricz1, Tushar D Bhagat1, Shanisha Gordon-Mitchell1, Mersedeh Rohanizadegan1, Lauren Hooda1, Ishan Datt1, Bartlomiej P Przychodzen2, Simrit Parmar3, Shahina Maqbool1, Jaroslaw P Maciejewski2, Ulrich Steidl1, John M Greally1, Amit Verma1.   

Abstract

The MLL3 gene has been shown to be recurrently mutated in many malignancies including in families with acute myeloid leukemia. We demonstrate that many MLL3 variant calls made by exome sequencing are false positives due to misalignment to homologous regions, including a region on chr21, and can only be validated by long-range PCR. Numerous other recurrently mutated genes reported in COSMIC and TCGA databases have pseudogenes and cannot also be validated by conventional short read-based sequencing approaches. Genome-wide identification of pseudogene regions demonstrates that frequency of these homologous regions is increased with sequencing read lengths below 200 bps. To enable identification of poor quality sequencing variants in prospective studies, we generated novel genome-wide maps of regions with poor mappability that can be used in variant calling algorithms. Taken together, our findings reveal that pseudogene regions are a source of false-positive mutations in cancers.

Entities:  

Keywords:  AML; MLL3; pseudogenes

Year:  2019        PMID: 31288594     DOI: 10.1080/10428194.2019.1630620

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  2 in total

Review 1.  The significance of CUX1 and chromosome 7 in myeloid malignancies.

Authors:  Matthew R M Jotte; Megan E McNerney
Journal:  Curr Opin Hematol       Date:  2022-03-01       Impact factor: 3.284

2.  Cell-free DNA captures tumor heterogeneity and driver alterations in rapid autopsies with pre-treated metastatic cancer.

Authors:  Bernard Pereira; Christopher T Chen; Lipika Goyal; Charlotte Walmsley; Christopher J Pinto; Islam Baiev; Read Allen; Laura Henderson; Supriya Saha; Stephanie Reyes; Martin S Taylor; Donna M Fitzgerald; Maida Williams Broudo; Avinash Sahu; Xin Gao; Wendy Winckler; A Rose Brannon; Jeffrey A Engelman; Rebecca Leary; James R Stone; Catarina D Campbell; Dejan Juric
Journal:  Nat Commun       Date:  2021-05-27       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.